Share on LinkedInShare on LinkedIn

ARTICLE · 03 APRIL 2020

COVID-19 Emergency Response Act: Amendments To The Patent Act

Gowling WLG
Gowling WLG
Contributor
Gowling WLG

Gowling WLG

The firm The firm’s lawyers speak English, French, Russian and Ukrainian. The firm’s client base...

View firm profile
Explore more from Gowling WLG

After lengthy deliberations, the Federal Government has passed an aid bill in response to the COVID-19 pandemic (COVID-19 Emergency Response Act).

CanadaCoronavirus (COVID-19)

After lengthy deliberations, the Federal Government has passed an aid bill in response to the COVID-19 pandemic (COVID-19 Emergency Response Act). The legislation received royal assent at roughly 1:30 p.m. on March 25.

The new legislation introduces significant amendments to the Patent Act (the "Act"). Specifically, section 19 of the Act ("Use of Patents by Government") is amended by adding the new section 19.4 that says, upon Application of the Minister of Health, the Commissioner of Patents shall authorize the Government of Canada and any person specified in the application to make, construct, use and sell a patented invention to the extent necessary to respond to the public health emergency described in the application.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from